Technical Analysis

Glenmark Pharmaceuticals (₹395.4): Sell

Akhil Nallamuthu |BL Research Bureau | Updated on: Jun 08, 2022

Traders can go short on the stock at the current price level

The stock of Glenmark Pharmaceuticals has been on a downtrend since July 2021 after facing resistance around ₹690.

That said, it was largely oscillating within the range of ₹385-410 for the past one month. However, it broke below the lower end of the range on Tuesday. Although it rallied on Wednesday, it is most likely to be a corrective one and there could be fresh selloffs in the upcoming sessions.

Since it has pulled back on Wednesday following a breakdown, it gives us an opportunity to consider this stock for intra-day short positions in Thursday's session. Traders can go short on the stock at the current price level of around ₹395. Place stop-loss at ₹405 as a rally beyond ₹400 might not happen, at least on Thursday. Exit the shorts when the price falls to ₹375. Those who wish to carry the shorts can do so for a target of ₹340 in a month or so. But if the stock opens above ₹400 on Thursday, refrain from trading.

(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)

Published on June 09, 2022
COMMENTS
  1. Comments will be moderated by The Hindu editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.

You May Also Like

Recommended for you